Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05337943 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Therapy and Light Therapy

A NA study of Insomnia and Fatigue, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT05337943: Completed NA study of Insomnia and Fatigue, sponsored by University of Pennsylvania.

NCT05337943 is a NA study of Insomnia and Fatigue that has completed, run by University of Pennsylvania. The registered enrollment target is 6 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05337943, a NA study of Insomnia and Fatigue, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

Cognitive behavioral therapy (CBT-I) is a common treatment for insomnia that does not use medications. While CBT-I is effective for insomnia, it does not tend to improve the waking symptom of fatigue. Another treatment, Bright Light Therapy, is used for treating seasonal depression and sleep disorders, and may improve fatigue and physical activity in individuals with PAH. The purpose of this study to assess the effects of Bright Light Therapy compared to CBT-I to treat insomnia and fatigue in patients with PAH.

Primary Outcome

Number of participants who completed all study procedures.

Interventions

  • BEHAVIORAL CBT-I
  • DEVICE Bright Light Therapy

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-01-12
Est. Completion 2024-05-31
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT05337943 record still lists

NCT05337943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which CBT-I is the first listed.

NCT05337943 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05337943 about?

NCT05337943 is a clinical study titled "Cognitive Behavioral Therapy and Light Therapy". Cognitive behavioral therapy (CBT-I) is a common treatment for insomnia that does not use medications. While CBT-I is effective for insomnia, it does not tend to improve the waking symptom of fatigue. Another treatment, Bright Light Therapy, is used for treating seasonal depression and sleep disorde...

What is the current status of trial NCT05337943?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-01-12. Estimated completion is 2024-05-31.

What conditions does trial NCT05337943 study?

This clinical trial studies the following conditions: Insomnia, Fatigue, Pulmonary Hypertension.

What interventions are being tested in trial NCT05337943?

The interventions under investigation include: CBT-I (BEHAVIORAL), Bright Light Therapy (DEVICE).

Who is sponsoring clinical trial NCT05337943?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05337943 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05337943's enrollment target sits among peer trials

6 151st of 151 higher than 1 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05337943, the US trial registry maintained by the National Library of Medicine. NCT05337943 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.